These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 16402086

  • 1. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
    Kubota T, Nakajima-Taniguchi C, Fukuda T, Funamoto M, Maeda M, Tange E, Ueki R, Kawashima K, Hara H, Fujio Y, Azuma J.
    Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.
    Schoedel KA, Hoffmann EB, Rao Y, Sellers EM, Tyndale RF.
    Pharmacogenetics; 2004 Sep; 14(9):615-26. PubMed ID: 15475735
    [Abstract] [Full Text] [Related]

  • 9. The role of CYP2A6 in the emergence of nicotine dependence in adolescents.
    Audrain-McGovern J, Al Koudsi N, Rodriguez D, Wileyto EP, Shields PG, Tyndale RF.
    Pediatrics; 2007 Jan; 119(1):e264-74. PubMed ID: 17130279
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Genetic variation in CYP2A6-mediated nicotine metabolism alters smoking behavior.
    Tyndale RF, Sellers EM.
    Ther Drug Monit; 2002 Feb; 24(1):163-71. PubMed ID: 11805739
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A common genetic defect in nicotine metabolism decreases risk for dependence and lowers cigarette consumption.
    Tyndale RF, Pianezza ML, Sellers EM.
    Nicotine Tob Res; 1999 Feb; 1 Suppl 2():S63-7; discussion S69-70. PubMed ID: 11768189
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers.
    O'Loughlin J, Paradis G, Kim W, DiFranza J, Meshefedjian G, McMillan-Davey E, Wong S, Hanley J, Tyndale RF.
    Tob Control; 2004 Dec; 13(4):422-8. PubMed ID: 15564629
    [Abstract] [Full Text] [Related]

  • 19. Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6?
    Verde Z, Santiago C, Rodríguez González-Moro JM, de Lucas Ramos P, López Martín S, Bandrés F, Lucia A, Gómez-Gallego F.
    Pharmacopsychiatry; 2014 Jan; 47(1):33-6. PubMed ID: 24127329
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.